LL-37

LL-37 is a naturally occurring antimicrobial peptide that plays an important role in the human immune system. It belongs to the cathelicidin family and is the only known human cathelicidin antimicrobial peptide. LL-37 is produced from a larger precursor protein called hCAP18, which is encoded by the CAMP gene. When this precursor is processed, it releases the active LL-37 peptide, which consists of 37 amino acids.

LL-37 helps the body defend itself against certain microorganisms, including bacteria, viruses, and fungi. One of its main functions is to interact with microbial membranes, which can contribute to the disruption of certain pathogens. Beyond its antimicrobial activity, LL-37 also participates in immune regulation by influencing the activity of immune cells and signaling molecules.

Research has shown that LL-37 may also be involved in wound healing and tissue repair. It can interact with cells involved in inflammation, blood vessel formation, and the restoration of damaged tissue. These properties have made LL-37 a subject of interest in research related to skin health, infection control, and regenerative medicine.

LL-37 is naturally present in tissues and secretions such as the skin, respiratory tract, and other epithelial surfaces. Its activity is carefully regulated because excessive or uncontrolled activity may contribute to inflammation in certain conditions.

Although LL-37 has demonstrated promising biological properties in laboratory and experimental studies, more research is needed to fully understand its potential applications, safety, and effectiveness in humans. It should not be considered an established treatment for infections, wounds, or other medical conditions without appropriate clinical evidence and medical guidance.